EDGAR Filing Documents for 0001636050-21-000065

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001636050-21-000065

Filing Date

2021-08-06

Accepted

2021-08-06 16:16:36

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	sioxdefa14aaugust2021.htm	DEFA14A	18346
2	GRAPHIC	sioxproxynotice_page1.jpg	GRAPHIC	105049
3	GRAPHIC	sioxproxynotice_page2.jpg	GRAPHIC	101771
	Complete submission text file	0001636050-21-000065.txt		293902

Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036

Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891

Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-37418 | Film No.: 211153107
SIC: 2834 Pharmaceutical Preparations